Analysts Viewpoint
SILO Pharma Inc’s latest rating changes from various analysts
SILO Pharma Inc’s recent filing unveils that its Chief Executive Officer Weisblum Eric acquired Company’s shares for reported $4329.0 on
Menu
SILO Pharma Inc’s recent filing unveils that its Chief Executive Officer Weisblum Eric acquired Company’s shares for reported $4329.0 on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. SILO Pharma
SILO Pharma Inc’s filing revealed that its Chief Executive Officer Weisblum Eric acquired Company’s shares for reported $4329.0 on May